<DOC>
	<DOCNO>NCT01158924</DOCNO>
	<brief_summary>Study show safety , tolerability preliminary effectiveness Intradiscal rhGDF-5 subject early lumbar disc degeneration .</brief_summary>
	<brief_title>A Clinical Trial Evaluate Safety , Tolerability Preliminary Effectiveness Single Administration Intradiscal rhGDF-5 Treatment Early Stage Lumbar Disc Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Persistent low back pain least 3 month nonsurgical therapy one two suspect symptomatic lumbar level ( L3/L4 L5/S1 ) . The recruiting physician use standard clinical radiological practice determine one/two disc level ( ) treat , i.e. , limited combination MRI , CT and/or Technetium bone scan , functional xrays , input spinal injection program ( target facet joint and/or epidural space ) discography ( discogram perform within 12 month anticipate study treatment date acceptable , long subject accident reinjury ) . 2 . Oswestry Disability Index ( ODI ) low back pain 30 great 3 . Low Back Pain score great equal 4 cm measure Visual Analog Scale ( VAS ) Visit 1 Baseline 4 . Male Female 18 year age old 1 . Persons unable MRI 2 . Abnormal neurological exam baseline ( e.g. , chronic radiculopathy ) 3 . Persons neurological radiographic evidence active radicular pain due anatomical compression stenosis disc herniation ( person somatic refer pain allow ) 4 . Suspected symptomatic facet joint and/or severe facet joint degeneration index level ( ) adjacent segment 5 . Suspected symptomatic sacroiliac joint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>